The tiny chip inside your smart phone, a SIM card, is the key to connecting to your cellular network. But nefarious actors have figured out how to weaponize thousands of them in swarm attacks to ...

Thirteen months into President Trump’s second term, his administration reports over 700,000 deportations—plus 2.2 million self-deportations. A major flashpoint: Minnesota, with 133,000 illegal ...

Full Measure is a weekly Sunday television news program focusing on investigative, original and accountability reporting. The managing editor and host is Sharyl Attkisson, five-time Emmy Award winner ...

Almost eight years ago, the Supreme Court ruled that government and other public sector workers can’t be forced to pay union ...

Polls show that public trust in the scientific establishment has suffered immensely in the wake of Covid. That’s prompted many to ask questions about conflicts of interest. Today, with the help of a ...

Full Measure is a weekly Sunday television news program focusing on investigative, original and accountability reporting. The managing editor and host is Sharyl Attkisson, five-time Emmy Award winner ...

In a shocking healthcare scheme under Obamacare, you paid $9000 a day, per addict, for months to put hundreds into luxury drug rehab. But not only did the patients not get treatment, some of them are ...

We begin with an investigation into the forces working to shape our information landscape when it comes to transgender policies. When an issue goes from zero to 60 practically overnight, grabbing ...

Today we begin with an investigation regarding the Covid-19 vaccine shortages. There are serious questions about an incorrect claim made by top scientists at CDC: the nation’s premiere public health ...

An update to our reporting on the Amish approach to Covid. In 2021, we reported that the Amish in Lancaster, Pennsylvania, rejected CDC guidelines and fared none the worse. A propaganda effort ...

Now an important update to our coverage of a new Alzheimer’s drug that drew so much controversy. Aducanumab was approved without one yes vote from the FDA advisory committee. In fact, several members ...

Today, we track what has to be one of the most alarming and egregious cases of a doctor putting profits over patients. It’s the shocking case of a Virginia OB-GYN who charmed his way into families' ...